Pluri Inc. Deferred Revenue (Non-Current)
Pluri Inc. (PLUR) had Deferred Revenue (Non-Current) of $2.37 million as of 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2016-09-07
- 2015-09-30: Deferred Revenue, Noncurrent $2.37M.
- 2015-06-30: Deferred Revenue, Noncurrent $2.47M.
- 2015-03-31: Deferred Revenue, Noncurrent $2.56M.
- 2014-12-31: Deferred Revenue, Noncurrent $2.66M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2015-09-30 | $2.37M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.47M 10-K · filed 2016-09-07 |
| 2015-03-31 | $2.56M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $2.66M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $2.75M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $2.85M 10-K · filed 2015-09-09 |
| 2014-03-31 | $2.94M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.04M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $3.13M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $3.23M 10-K · filed 2014-09-11 |
| 2013-03-31 | $2.92M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $3.12K 10-Q · filed 2013-01-31 |
| 2012-09-30 | $3.31M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $3.50M 10-K · filed 2013-09-11 |
| 2012-03-31 | $3.46M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $3.69M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $3.92M 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |